Clinical trial
Rosuvastatin and Renal Endothelial Function
NCT00160745 · University of Erlangen-Nürnberg Medical School, Other · Completed
Key facts
| NCT number | NCT00160745 |
|---|---|
| Title | Rosuvastatin and Renal Endothelial Function |
| Official title | A Randomised, Double-blind, Placebo-controlled, Mono-centre, Explorative Phase II Trial to Study the Effects of Rosuvastatin on Basal Production and Release of Nitric Oxide From the Renal Vasculature in Patients With Hypercholesterolemia. |
| Lead sponsor | University of Erlangen-Nürnberg Medical School, Other |
| Collaborators | AstraZeneca Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hypercholesterolemia |
| Intervention type | Drug |
| Interventions | Rosuvastatin |
| Enrollment | 46 |
| Completion | Sep 1, 2006 |
| First posted | Sep 12, 2005 |
| Last update posted | Feb 26, 2018 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: